Eduardo Leonardo2552 University Ave APT 35N, Bronx, NY 10468

Eduardo Leonardo Phones & Addresses

2552 University Ave APT 35N, Bronx, NY 10468

Work

Address: 119 W 57Th St, New York, NY 10019 Specialities: Psychiatrist

Education

School / High School: University Of California, San Francisco, School Of Medicine 1999

Languages

English • Spanish

Awards

Healthgrades Honor Roll

Ranks

Certificate: Psychiatry, 2004

Mentions for Eduardo Leonardo

Career records & work history

Medicine Doctors

Eduardo Leonardo Photo 1

Eduardo David Leonardo, New York NY

Specialties:
Psychiatrist
Address:
119 W 57Th St, New York, NY 10019
Education:
Medical School - University of California, San Francisco
University of California, San Francisco (PhD)
NewYork-Presbyterian Hospital / Columbia University Medical Center (Internship)
Columbia University, New York State Psychiatric Institute (Residency)
Columbia University, New York State Psychiatric Institute (Fellowship)
Yale University (Bachelor’s)
Languages:
English
Spanish
Awards and Publications:
Richardson-Jones, J.W., Craige, C.P., Guiard, B.P., Stephen, A.K., Metzger, K.L., Kung, H.F., Gardier, A.M., Dranovsky, A., David, D.J., Beck, S.G., Hen, R., and *Leonardo, E.D. : 5-HT1A autoreceptors determine vulnerability to stress and response to antidepressants. Neuron 2010;65: 40-52
Dranovsky A, Leonardo ED.: Is there a role for young hippocampal neurons in adaptation to stress. Behav Brain Res 2012;227(2): 371-375
Surget A, Tanti A, Leonardo ED, Laugeray A, Rainer Q, Touma C, Palme R, Griebel G, Ibarguen-Vargas Y, Hen R, Belzung C.: Antidepressants recruit new neurons to improve stress response regulation. Molecular Psychiatry 2011;16(12): 1177-1188
Board certifications:
American Board of Psychiatry and Neurology
Hospital affiliations:
New York-Presbyterian Hospital / Columbia University Medical Center
About:
Dr. Eduardo David Leonardo is a caring psychiatrist serving patients in greater New York City. He is certified by the American Board of Psychiatry and Neurology. Dr. Leonardo is a...
Eduardo Leonardo Photo 2

Dr. Eduardo D Leonardo, New York NY - MD (Doctor of Medicine)

Specialties:
Psychiatry
Neuropsychiatry (Psychiatry)
Address:
119 W 57Th St Suite 620, New York, NY 10019
(917) 751-5542 (Phone)
Conditions:
Anxiety
Depressive Disorders
Certifications:
Psychiatry, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Education:
Medical School
University Of California, San Francisco, School Of Medicine
Graduated: 1999
Medical School
Columbia Presby
Graduated: 2000
Medical School
Columbia Psyc Nyph/Nyspi
Graduated: 2003
Medical School
Columbia University
Graduated: 2003

Eduardo D. Leonardo

Specialties:
Psychiatry
Work:
Eduardo Leonardo MD
119 W 57 St STE 620, New York, NY 10019
(917) 751-5542 (phone)
Education:
Medical School
University of California, San Francisco School of Medicine
Graduated: 1999
Conditions:
Anxiety Phobic Disorders, Attention Deficit Disorder (ADD), Bipolar Disorder, Depressive Disorders
Languages:
English
Description:
Dr. Leonardo graduated from the University of California, San Francisco School of Medicine in 1999. He works in New York, NY and specializes in Psychiatry.

Eduardo Leonardo resumes & CV records

Resumes

Eduardo Leonardo Photo 30

Eduardo Edward Leonardo

Eduardo Leonardo Photo 31

Eduardo Leonardo

Eduardo Leonardo Photo 32

Eduardo Leonardo

Publications & IP owners

Us Patents

Assay For Screening Antidepressants

US Patent:
2011029, Dec 1, 2011
Filed:
Dec 1, 2009
Appl. No.:
13/131558
Inventors:
Rene Hen - Tenafly NJ, US
Jingwen Wang - New york NY, US
Eduardo David Leonardo - River Edge NJ, US
Jesse Richardson-Jones - New York NY, US
International Classification:
G01N 33/48
A01K 67/00
G01N 33/82
A61K 49/00
C12Q 1/68
US Classification:
800 3, 424 91, 435 612, 435 75, 800 9
Abstract:
This invention provides a method for identifying a small molecule as an antidepressant, a method for identifying a small molecule as an anxiolytic, and a method for identifying a small molecule as able to increase dendritic arborization, decrease expression of an immaturity marker, increase expression of a maturity marker, or enhance artificial cerebrospinal fluid-type long-term potentiation in central nervous system. This invention also provides a transgenic mouse model for SSRI-non-responders.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.